Entresto Interactions
There are 348 drugs known to interact with Entresto (sacubitril/valsartan), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 34 are major, 310 are moderate, and 4 are minor.
- View all 348 medications that may interact with Entresto
- View Entresto alcohol/food interactions (2)
- View Entresto disease interactions (7)
Most frequently checked interactions
View interaction reports for Entresto (sacubitril / valsartan) and the medicines listed below.
- albuterol
- allopurinol
- amiodarone
- amlodipine
- aspirin
- atorvastatin
- carvedilol
- clopidogrel
- digoxin
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- furosemide
- gabapentin
- Jardiance (empagliflozin)
- Lasix (furosemide)
- levothyroxine
- magnesium oxide
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- pantoprazole
- potassium chloride
- rosuvastatin
- spironolactone
- tamsulosin
- torsemide
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Entresto alcohol/food interactions
There are 2 alcohol/food interactions with Entresto (sacubitril / valsartan).
Entresto disease interactions
There are 7 disease interactions with Entresto (sacubitril / valsartan) which include:
More about Entresto (sacubitril / valsartan)
- Entresto consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (200)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: angiotensin receptor blockers and neprilysin inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.